Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Feb;23(2):418–423. doi: 10.1128/iai.23.2.418-423.1979

Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus.

M J Tocci, S C St Jeor
PMCID: PMC414181  PMID: 217829

Abstract

Human lymphoblastoid cells of B- and T-cell origin were examined for their in vitro susceptibility to infection with human cytomegalovirus (CMV). Results of infectious-center assays, at virus to cell ratios of 10, indicated that in each of the lymphoblastoid cell lines tested less than 1% of the cells produced infectious virus. Under these conditions, CMV specific antigens were undetectable. Infection of lymphoblastoid cells with CMV resulted in atypical virus growth curves similar to those obtained with persistently infected human embryonic kidney cells. Although some variation existed in the relative sensitivity of lymphoblasts, cells of B (Raji, P3J-HR-1, RPMI 8226) and T (CCRF-CEM) origin were susceptible to infection with CMV. Variation in the sensitivity of lymphoblasts to CMV infection did not correlate with differences in virus adsorption or the presence of Epstein-Barr virus deoxyribonucleic acid. These studies suggest that human lymphoblastoid cells could serve as a model to examine persistent CMV infection in lymphoid cells of various origin.

Full text

PDF
418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Ely M., Steger L. Post-transfusion cytomegaloviremia and persistence of cytomegalovirus in blood. Infect Immun. 1971 Jan;3(1):159–163. doi: 10.1128/iai.3.1.159-163.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. EPSTEIN M. A., BARR Y. M. CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA. Lancet. 1964 Feb 1;1(7327):252–253. doi: 10.1016/s0140-6736(64)92354-2. [DOI] [PubMed] [Google Scholar]
  3. Epstein M. A., Achong B. G., Barr Y. M., Zajac B., Henle G., Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst. 1966 Oct;37(4):547–559. [PubMed] [Google Scholar]
  4. FOLEY G. E., LAZARUS H., FARBER S., UZMAN B. G., BOONE B. A., MCCARTHY R. E. CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer. 1965 Apr;18:522–529. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. Fiala M., Payne J. E., Berne T. V., Moore T. C., Henle W., Montgomerie J. Z., Chatterjee S. N., Guze L. B. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis. 1975 Oct;132(4):421–433. doi: 10.1093/infdis/132.4.421. [DOI] [PubMed] [Google Scholar]
  6. Gehrz R. C., Marker S. C., Knorr S. O., Kalis J. M., Balfour H. H., Jr Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet. 1977 Oct 22;2(8043):844–847. doi: 10.1016/s0140-6736(77)90782-6. [DOI] [PubMed] [Google Scholar]
  7. Harnden D. G., Elsdale T. R., Young D. E., Ross A. The isolation of cytomegalovirus from peripheral blood. Blood. 1967 Jul;30(1):120–125. [PubMed] [Google Scholar]
  8. Hinuma Y., Grace J. T., Jr Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures. Proc Soc Exp Biol Med. 1967 Jan;124(1):107–111. doi: 10.3181/00379727-124-31677. [DOI] [PubMed] [Google Scholar]
  9. Huang Y. T., Huang E. S., Pagano J. S. Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol. 1974 Feb;112(2):528–532. [PubMed] [Google Scholar]
  10. Joncas J. H., Menezes J., Huang E. S. Persistence of CMV genome in lymphoid cells after congenital infection. Nature. 1975 Dec 4;258(5534):432–434. doi: 10.1038/258432a0. [DOI] [PubMed] [Google Scholar]
  11. Lang D. J., Noren B. Cytomegaloviremia following congenital infection. J Pediatr. 1968 Dec;73(6):812–819. doi: 10.1016/s0022-3476(68)80233-1. [DOI] [PubMed] [Google Scholar]
  12. Matsuoka Y., Moore G. E., Yagi Y., Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1246–1250. doi: 10.3181/00379727-125-32327. [DOI] [PubMed] [Google Scholar]
  13. Minowada J., Onuma T., Moore G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972 Sep;49(3):891–895. [PubMed] [Google Scholar]
  14. Mirkovic R., Werch J., South M. A., Benyesh-Melnick M. Incidence of cytomegaloviremia in blood-bank donors and in infants with congenital cytomegalic inclusion disease. Infect Immun. 1971 Jan;3(1):45–50. doi: 10.1128/iai.3.1.45-50.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Olding L. B., Jensen F. C., Oldstone M. B. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med. 1975 Mar 1;141(3):561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PULVERTAFT J. V. A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE. J Clin Pathol. 1965 May;18:261–273. doi: 10.1136/jcp.18.3.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pattengale P. K., Smith R. W., Gerber P. B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Natl Cancer Inst. 1974 Apr;52(4):1081–1086. doi: 10.1093/jnci/52.4.1081. [DOI] [PubMed] [Google Scholar]
  18. Rinaldo C. R., Jr, Black P. H., Hirsch M. S. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis. 1977 Nov;136(5):667–678. doi: 10.1093/infdis/136.5.667. [DOI] [PubMed] [Google Scholar]
  19. Rola-Pleszczynski M., Frenkel L. D., Fuccillo D. A., Hensen S. A., Vincent M. M., Reynolds D. W., Stagno S., Bellanti J. A. Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis. 1977 Mar;135(3):386–391. doi: 10.1093/infdis/135.3.386. [DOI] [PubMed] [Google Scholar]
  20. Schauf V., Strelkauskas A. J., Deveikis A. Alteration of lymphocyte subpopulations with cytomegalovirus infection in infancy. Clin Exp Immunol. 1976 Dec;26(3):478–483. [PMC free article] [PubMed] [Google Scholar]
  21. St Jeor S., Rapp F. Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridine. J Virol. 1973 Jun;11(6):986–990. doi: 10.1128/jvi.11.6.986-990.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. St Jeor S., Rapp F. Cytomegalovirus: conversion of nonpermissive cells to a permissive state for virus replication. Science. 1973 Sep 14;181(4104):1060–1061. doi: 10.1126/science.181.4104.1060. [DOI] [PubMed] [Google Scholar]
  23. St Jeor S., Weisser A. Persistence of cytomegalovirus in human lymphoblasts and peripheral leukocyte cultures. Infect Immun. 1977 Feb;15(2):402–409. doi: 10.1128/iai.15.2.402-409.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wentworth B. B., French L. Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med. 1970 Nov;135(2):253–258. doi: 10.3181/00379727-135-35031. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES